blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2512242

EP2512242 - NOVEL COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.08.2016
Database last updated on 26.06.2024
Most recent event   Tooltip19.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 21.11.2018  [2018/47]
Applicant(s)For all designated states
GlaxoSmithKline Intellectual Property Limited
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2015/44]
Former [2014/44]For all designated states
GlaxoSmithKline Intellectual Property Development Limited
980 Great West Road
Brentford
Middlesex TW8 9GS / GB
Former [2012/43]For all designated states
Glaxo Wellcome Manufacturing Pte Ltd
1 Pioneer Sector 1
Jurong 628413 / SG
Inventor(s)01 / CHEN, Deborah
c/o GlaxoSmithKline
R&D China Singapore Research Centre
11 Biopolis Way The Helios 06-03/04
Commonwealth 138667 / SG
02 / LEE, Kiew, Ching
c/o GlaxoSmithKline
R&D China Singapore Research Centre
11 Biopolis Way The Helios 06-03/04
Commonwealth 138667 / SG
03 / TERRELL, Lamont, Roscoe
c/o GlaxoSmithKline
Global Patents
709 Swedeland Road
King of Prussia
PA 19406 / US
 [2012/43]
Representative(s)Drury, Elizabeth Anne
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2015/40]
Former [2012/43]Drury, Elizabeth Anne
GlaxoSmithKline
Global Patents CN925.1
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date10838240.916.12.2010
[2015/40]
WO2010US60696
Priority number, dateUS20090287798P18.12.2009         Original published format: US 287798 P
[2012/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011075559
Date:23.06.2011
Language:EN
[2011/25]
Type: A1 Application with search report 
No.:EP2512242
Date:24.10.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 23.06.2011 takes the place of the publication of the European patent application.
[2012/43]
Type: B1 Patent specification 
No.:EP2512242
Date:30.09.2015
Language:EN
[2015/40]
Type: B8 Corrected title page of specification 
No.:EP2512242
Date:09.12.2015
[2015/50]
Search report(s)International search report - published on:US23.06.2011
(Supplementary) European search report - dispatched on:EP30.07.2013
ClassificationIPC:C07D495/04, A61K31/4365, A61P25/28
[2013/35]
CPC:
C07D495/04 (EP,US); A61K31/4365 (EP,US); A61P17/02 (EP);
A61P21/02 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); A61P9/12 (EP) (-)
Former IPC [2012/43]A01N43/42
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUARTIGE VERBINDUNGEN[2012/43]
English:NOVEL COMPOUNDS[2012/43]
French:NOUVEAUX COMPOSÉS[2012/43]
Entry into regional phase05.07.2012National basic fee paid 
05.07.2012Search fee paid 
05.07.2012Designation fee(s) paid 
05.07.2012Examination fee paid 
Examination procedure05.07.2012Examination requested  [2012/43]
18.02.2014Amendment by applicant (claims and/or description)
21.11.2014Communication of intention to grant the patent
06.03.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
29.04.2015Communication of intention to grant the patent
21.08.2015Fee for grant paid
21.08.2015Fee for publishing/printing paid
21.08.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.11.2014
Opposition(s)01.07.2016No opposition filed within time limit [2016/36]
Fees paidRenewal fee
07.12.2012Renewal fee patent year 03
06.12.2013Renewal fee patent year 04
05.12.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.12.2010
AL30.09.2015
AT30.09.2015
BE30.09.2015
BG30.09.2015
CY30.09.2015
CZ30.09.2015
DK30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
MK30.09.2015
MT30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SI30.09.2015
SK30.09.2015
SM30.09.2015
TR30.09.2015
IE16.12.2015
LU16.12.2015
NO30.12.2015
CH31.12.2015
GR31.12.2015
LI31.12.2015
IS30.01.2016
PT01.02.2016
[2018/47]
Former [2018/30]HU16.12.2010
AT30.09.2015
BE30.09.2015
BG30.09.2015
CY30.09.2015
CZ30.09.2015
DK30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
MK30.09.2015
MT30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SI30.09.2015
SK30.09.2015
SM30.09.2015
TR30.09.2015
IE16.12.2015
LU16.12.2015
NO30.12.2015
CH31.12.2015
GR31.12.2015
LI31.12.2015
IS30.01.2016
PT01.02.2016
Former [2017/38]HU16.12.2010
AT30.09.2015
BE30.09.2015
BG30.09.2015
CY30.09.2015
CZ30.09.2015
DK30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
MT30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SI30.09.2015
SK30.09.2015
SM30.09.2015
IE16.12.2015
LU16.12.2015
NO30.12.2015
CH31.12.2015
GR31.12.2015
LI31.12.2015
IS30.01.2016
PT01.02.2016
Former [2017/03]AT30.09.2015
BE30.09.2015
CZ30.09.2015
DK30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SI30.09.2015
SK30.09.2015
IE16.12.2015
LU16.12.2015
NO30.12.2015
CH31.12.2015
GR31.12.2015
LI31.12.2015
IS30.01.2016
PT01.02.2016
Former [2016/49]AT30.09.2015
CZ30.09.2015
DK30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SI30.09.2015
SK30.09.2015
IE16.12.2015
LU16.12.2015
NO30.12.2015
BE31.12.2015
CH31.12.2015
GR31.12.2015
LI31.12.2015
IS30.01.2016
PT01.02.2016
Former [2016/46]AT30.09.2015
CZ30.09.2015
DK30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SK30.09.2015
IE16.12.2015
LU16.12.2015
NO30.12.2015
BE31.12.2015
CH31.12.2015
GR31.12.2015
LI31.12.2015
IS30.01.2016
PT01.02.2016
Former [2016/45]AT30.09.2015
CZ30.09.2015
DK30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SK30.09.2015
IE16.12.2015
LU16.12.2015
NO30.12.2015
BE31.12.2015
GR31.12.2015
IS30.01.2016
PT01.02.2016
Former [2016/39]AT30.09.2015
CZ30.09.2015
DK30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SK30.09.2015
LU16.12.2015
NO30.12.2015
BE31.12.2015
GR31.12.2015
IS30.01.2016
PT01.02.2016
Former [2016/34]AT30.09.2015
CZ30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SK30.09.2015
LU16.12.2015
NO30.12.2015
BE31.12.2015
GR31.12.2015
IS30.01.2016
PT01.02.2016
Former [2016/33]AT30.09.2015
CZ30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
MC30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SK30.09.2015
NO30.12.2015
BE31.12.2015
GR31.12.2015
IS30.01.2016
PT01.02.2016
Former [2016/24]AT30.09.2015
CZ30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
NL30.09.2015
PL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SK30.09.2015
NO30.12.2015
BE31.12.2015
GR31.12.2015
IS30.01.2016
PT01.02.2016
Former [2016/23]CZ30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
NL30.09.2015
RO30.09.2015
RS30.09.2015
SE30.09.2015
SK30.09.2015
NO30.12.2015
GR31.12.2015
IS30.01.2016
Former [2016/22]CZ30.09.2015
EE30.09.2015
FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
NL30.09.2015
RS30.09.2015
SE30.09.2015
NO30.12.2015
GR31.12.2015
IS30.01.2016
Former [2016/10]FI30.09.2015
HR30.09.2015
LT30.09.2015
LV30.09.2015
RS30.09.2015
SE30.09.2015
NO30.12.2015
GR31.12.2015
Former [2016/09]FI30.09.2015
LT30.09.2015
LV30.09.2015
NO30.12.2015
GR31.12.2015
Former [2016/08]LT30.09.2015
NO30.12.2015
Former [2016/07]LT30.09.2015
Documents cited:Search[A]EP1505068  (SHIONOGI & CO [JP]) [A] 1-14 * page 1, paragraph 1 - page 2, paragraph 9; example -; claim - *;
 [A]EP1598354  (VASOPHARM BIOTECH GMBH [DE]) [A] 1-14 * page 1, paragraph 1 - paragraph 11; example -; claim - *
International search[Y]US2007082880  (BOSCHELLI DIANE H [US], et al);
 [Y]  - XU ET AL, "Catalytic Domain Crystal Structure of Protein Kinase C-theta", JBC, (20041126), vol. 279, no. 48, pages 50401 - 50409, XP002376549

DOI:   http://dx.doi.org/10.1074/jbc.M409216200
by applicantEP1598354
 EP1505068
    - ZHOU ET AL., HYPERTENSION, (2006), vol. 47, pages 81 - 86
    - BENDALL ET AL., CIRCULATION, (2002), vol. 105, pages 293 - 296
    - JOHAR ET AL., FASEB J., (2006), vol. 20, pages 1546 - 1548
    - WALDER ET AL., STROKE, (1997), vol. 28, pages 2252 - 2258
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.